NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis $26.78 +0.09 (+0.34%) Closing price 04:00 PM EasternExtended Trading$26.78 +0.00 (+0.02%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Surgery Partners Stock (NASDAQ:SGRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Surgery Partners alerts:Sign Up Key Stats Today's Range$26.62▼$26.9650-Day Range$13.23▼$26.9652-Week Range$11.41▼$27.23Volume1.11 million shsAverage Volume2.26 million shsMarket Capitalization$3.50 billionP/E RatioN/ADividend YieldN/APrice Target$20.70Consensus RatingHold Company Overview Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems. The company focuses on providing care in settings designed for surgical procedures outside traditional acute-care hospitals.AI Generated. May Contain Errors. Read More Surgery Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreSGRY MarketRank™: 1.457733936155 of 5 starsSurgery Partners scored higher than 29% of companies evaluated by MarketBeat, and ranked 729th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingSurgery Partners has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on no strong buy ratings, 2 buy ratings, 9 hold ratings, and 1 sell rating.Downside RiskSurgery Partners has a consensus price target of $20.70, representing about 22.8% downside from its current price of $26.82.Amount of Analyst CoverageSurgery Partners has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Surgery Partners' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Surgery Partners are expected to decrease in the coming year, from $0.14 to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -39.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -39.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.98% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 1.05, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Surgery Partners has recently decreased by 37.54%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment0.49 News SentimentSurgery Partners has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Surgery Partners this week, compared to 4 articles on an average week.Search Interest5 people have searched for SGRY on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows2 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have not sold or bought any company stock.Percentage Held by Insiders2.00% of the stock of Surgery Partners is held by insiders.Percentage Held by InstitutionsSurgery Partners has minimal institutional ownership at this time.Read more about Surgery Partners' insider trading history. Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGRY Stock News HeadlinesSGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its ShareholdersNovember 19 at 7:38 PM | globenewswire.comSGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners's $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for ShareholdersNovember 19 at 4:52 PM | globenewswire.comThis is likely to EXPLODEDr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.November 20 at 1:00 AM | Weiss Ratings (Ad)Surgery Center Holdings, Inc. Announces Increased Consent Fee In Consent Solicitation Relating To Its USD 1,225 million 7.25% Senior Notes Due 2032November 18 at 9:56 AM | marketscreener.comMSurgery Partners, Inc. Announces Increased Consent Fee in Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032November 18 at 9:56 AM | markets.businessinsider.comSurgery Partners Increases Consent Fee in Solicitation for 7.250% Senior Notes Due 2032November 18 at 7:51 AM | quiverquant.comQSurgery Partners, Inc. Announces Increased Consent Fee in Consent Solicitation Relating to Surgery Center Holdings, Inc.'s 7.250% Senior Notes due 2032November 18 at 7:30 AM | globenewswire.comSGRY Merger Investigation: Surgery Partners Investigated Over $23.50 per Share Take-Private Merger – Contact BFA Law if You Hold SharesNovember 18 at 6:36 AM | globenewswire.comSee More Headlines SGRY Stock Analysis - Frequently Asked Questions How have SGRY shares performed this year? Surgery Partners' stock was trading at $15.45 at the beginning of 2026. Since then, SGRY stock has increased by 73.6% and is now trading at $26.8240. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings data on Monday, November, 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Surgery Partners's quarterly revenue was down .8% compared to the same quarter last year. Is Surgery Partners doing a stock buyback? Surgery Partners' Board of Directors authorized a share repurchase program on Thursday, February 26th 2026, which authorizes the company to repurchase $200 million in shares, according to EventVestor. This means that the company could repurchase up to 9.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued. When did Surgery Partners IPO? Surgery Partners (SGRY) raised $350 million in an IPO on Thursday, October 1st 2015. The company issued 14,285,000 shares at a price of $23.00-$26.00 per share. Who are Surgery Partners' major shareholders? Top institutional shareholders of Surgery Partners include State Street Corp (1.72%), BROOKFIELD Corp ON (1.23%), BROOKFIELD Corp ON (1.23%) and Goldman Sachs Group Inc. (0.48%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, David T Doherty, Wayne S Deveydt, Harrison R Bane, Marissa Brittenham, Danielle Burkhalter, William Trenton Webb, Bradley R Owens and Teresa Deluca. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), GE Aerospace (GE), Palantir Technologies (PLTR), Tesla (TSLA) and Bristol Myers Squibb (BMY). Company Calendar Last Earnings11/09/2026Today11/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 SGRY's financial health is in the Green zone, according to TradeSmith. SGRY has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Facilities Current SymbolNASDAQ:SGRY CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees16,000Year Founded2004Price Target and Rating Average Price Target for Surgery Partners$20.70 High Price Target$25.00 Low Price Target$14.00 Potential Upside/Downside-22.7%Consensus RatingHold Rating Score (0-4)2.08 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$77.90 million Net Margins-2.59% Pretax Margin2.66% Return on Equity0.98% Return on Assets0.38% Debt Debt-to-Equity Ratio1.03 Current Ratio2.17 Quick Ratio2.01 Sales & Book Value Annual Sales$3.36 billion Price / Sales1.04 Cash Flow$1.70 per share Price / Cash Flow15.79 Book Value$22.16 per share Price / Book1.21Miscellaneous Outstanding Shares130,881,000Free Float128,263,000Market Cap$3.50 billion OptionableOptionable Beta1.85 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:SGRY) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.